Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.1392 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Sara Cahill und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
The respiratory virus SARS-CoV-2 has posed a significant health burden since its emergence. The virus primarily infects and replicates in epithelial cells in the respiratory tract, but SARS-CoV-2 viral RNA has also been detected in macrophages isolated from patients with COVID-19. However, how SARS-CoV-2 enters macrophages remains unclear.
Methods
To address this gap, we assessed the metabolic changes that SARS-CoV-2 induces in monocyte-derived and tissue resident macrophages and how this affects transcriptional responses and viral entry.
Results
Our studies suggest that SARS-CoV-2 triggers a TLR2-dependent pathway encompassing IRG1, an enzyme that produces the metabolite itaconate, and NRF2, a transcription factor, which is necessary for effective viral entry into macrophages. Through this mechanism, SARS-CoV-2 induces the NRF2 gene target Macrophage associated receptor with collagenous structure (MARCO) for entry. MARCO is a scavenger receptor that is basally expressed by tissue-resident macrophages and facilitates efferocytosis of unopsonized particles and pathogens. MARCO expression increases in macrophages following SARS-CoV-2 treatment in a TLR2, IRG1, and NRF2-dependent manner. Furthermore, SARS-CoV-2 is unable to effectively enter MARCO-deficient macrophages, suggesting that MARCO serves as an alternative viral entry receptor. Our data shows that MARCO is required for pyroptosis following SARS-CoV-2 infection. In vivo, pre-treatment of mice with an anti-MARCO blocking antibody reduces the severity of COVID-19. To understand how MARCO expression is regulated during infection, I determined that anti-viral type I IFN negatively regulates MARCO via inhibition of NRF2.
Conclusion
Together, these novel findings suggest that SARS-CoV-2 metabolically reprograms macrophages to induce MARCO expression and promote viral entry and pyroptosis in the absence of IFN signaling. This work identifies a novel, druggable host-pathogen interaction that dictates the severity of respiratory virus infection. Funding Source NIH/NIAID T32 AI095213 Topic Categories Viral Immunology (VIR)
Zitieren
APA
Cahill, S., Ramani, S., Finnegan, M., Learnard, H., Wang, J., Koupenova, M., Shmeul-Galia, L., & Humphries, F. (2026). Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1392
Vancouver
Cahill S, Ramani S, Finnegan M, Learnard H, Wang J, Koupenova M, et al. Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1392
BibTeX
@article{Cahill2026,
author = {Cahill, Sara and Ramani, Shriram and Finnegan, Matthew and Learnard, Heather and Wang, Jennifer and Koupenova, Milka and Shmeul-Galia, Liraz and Humphries, Fiachra},
title = {Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.1392}
}
EUVIMED